Will Warmer Weather Stop the Spread of the Coronavirus? Don ’t Count on It, Say Experts
As coronavirus continues to spread across the world, a simple solution has been repeated by some leaders: Warm summer temperatures will stop the outbreak in its tracks. U.S. President Donald Trump floated the idea that by April the coronavirus problem would solve itself. He told a crowd at a Feb. 10 rally in New Hampshire: “You know, in theory when it gets a little warmer, it miraculously goes away, that’s true.” In Southeast Asia, officials in Indonesia have offered the warm climate as the reason that no cases have been diagnosed there. “Indonesia’s air is not like the air in China that is subtropical,” said Achmad Yurianto, a senior official in Indonesia’s health ministry, in response to a study suggesting there are likely to be undetected cases in the country. However, infectious disease experts say while the factors that cause other viruses to retreat during the summer months could affect this coronavirus, called COVID-19, in a similar way, there’s no way to be sure. And, even if the virus’ spread does slow as temperatures rise, that doesn’t mean it will be gone for good. Why cold and flu decrease in the summer There’s precedent for the idea that the COVID-19 outbreak will collapse with the onset of summer. The common cold is most prevalent in the winter and spring, and influenza is most common during the fall and winter in the U.S., with flu activity peaking between December and February, according to the...
ConclusionCRC-OMD treatment represents a relevant part of the everyday clinical practice of the IR Italian centers with promising future prospects. Heterogeneity persists in clinical indications, requiring more robust evidence to set indications and to diffuse clinical applications.
Publication date: Available online 28 September 2020Source: Social Science ResearchAuthor(s): John Iceland, Ilana Redstone
Publication date: 1 January 2021Source: Personality and Individual Differences, Volume 168Author(s): Marta Bodecka, Iwona Nowakowska, Anna Zajenkowska, Joanna Rajchert, Izabela Kaźmierczak, Irena Jelonkiewicz
Conclusion: In this study, the total population of women suffering from different cervical lesions and malignancy was found to be infected with various HPV genotypes. High prevalence of HPV- 53 and HPV- 16 detected among participants with normal cytology can be considered as a tip-off development of cervical cancer among Iranian women. PMID: 32983939 [PubMed]
Conclusion: The early administration of oral bromhexine reduces the ICU transfer, intubation, and the mortality rate in patients with COVID-19. This affordable medication can easily be administered everywhere with a huge positive impact(s) on public health and the world economy. Altogether, the verification of our results on a larger scale and different medical centers is strongly recommended. Trial Registration: IRCT202003117046797N4; https://irct.ir/trial/46969. PMID: 32983936 [PubMed]
Authors: Assadiasl S, Fatahi Y, Zavvar M, Nicknam MH Abstract The newly emerged severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) has recently caused pandemic Coronavirus Disease-2019 (COVID-19). Considering the serious medical, economic and social consequences of this pandemic and the lack of definite medication and vaccine it is necessary to describe natural immune responses to the SARS-CoV-2 in order to exploit them for treating the patients and monitoring the general population. Moreover, detecting the most immunogenic antigens of the virus is fundamental for designing effective vaccines. Ant...
Authors: Samsami M, Mehravaran E, Tabarsi P, Javadi A, Arsang-Jang S, Komaki A, Taheri M, Ghafouri-Fard S Abstract Coronavirus disease 2019 (COVID-19) has caused a global pandemic in early 2020. This infectious disorder has a heterogeneous course ranging from asymptomatic disorder to a critical situation needing intensive cares. In the current study, we present a report of affected patients admitted in a single hospital in Iran. Eighty-two hospitalized patients with COVID-19 were assessed. Demographic, clinical, and paraclinical parameters were gathered and statistically analyzed. The median age (IQR) of the patien...
Publication date: October 2020Source: Pregnancy Hypertension, Volume 22Author(s): Yunha Noh, Seung-Ah Choe, Ju-Young Shin
Unfortunately, after publication, we found errors in the extraction of data on gestational diabetes and threatened miscarriage.
Concerns raised over an increased risk of severe COVID-19 outcomes in MS patients on anti-CD20 B-cell depleting drugs such as ocrelizumab and rituximab following presentation of new data.Medscape Medical News
More News: American Health | Australia Health | Brazil Health | Centers for Disease Control and Prevention (CDC) | China Health | Common Cold | Coronavirus | COVID-19 | Epidemiology | H1N1 | Health | Hong Kong Health | Indonesia Health | Infectious Diseases | Influenza | International Medicine & Public Health | Iran Health | Italy Health | Japan Health | Laboratory Medicine | MERS | Middle East Health | Outbreaks | Respiratory Medicine | SARS | South Korea Health | Study | Swine Flu | Trump | USA Health